Search by year - Any -202620252024202320222021202020192018201720162015 24 March 2026 Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures Non-regulated information 10 March 2026 Biocartis Receives European IVDR Certification for the Idylla CDx MSI Test Non-regulated information 12 January 2026 Biocartis to Collaborate with Mayo Clinic on Breast Cancer Gene Signatures Non-regulated information 14 November 2025 Biocartis Showcases Growing Impact of Idylla Platform at AMP 2025 Non-regulated information 15 September 2025 Biocartis Receives FDA Approval for the Idylla CDx MSI Test Non-regulated information 18 August 2025 Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Non-regulated information 17 June 2025 Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing Non-regulated information 2 June 2025 Biocartis Announces IVDR Class C CDx Certification of the Idylla EGFR Mutation Test Non-regulated information 2 April 2025 Biocartis Announces Launch of the Brand-New Idylla POLE-POLD1 Mutation Assay Non-regulated information 18 March 2025 Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting Non-regulated information Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »